Paul Newhouse
Last active: 3/3/2020

Glutamate-sensitive imaging and evaluation of cognitive impairment in multiple sclerosis.

O'Grady KP, Dula AN, Lyttle BD, Thompson LM, Conrad BN, Box BA, McKeithan LJ, Pawate S, Bagnato F, Landman BA, Newhouse P, Smith SA
Mult Scler. 2019 25 (12): 1580-1592

PMID: 30230400 · PMCID: PMC6424643 · DOI:10.1177/1352458518799583

BACKGROUND - Cognitive impairment (CI) profoundly impacts quality of life for patients with multiple sclerosis (MS). Dysfunctional regulation of glutamate in gray matter (GM) has been implicated in the pathogenesis of MS by post-mortem pathological studies and in CI by in vivo magnetic resonance spectroscopy, yet GM pathology is subtle and difficult to detect using conventional T- and T-weighted magnetic resonance imaging (MRI). There is a need for high-resolution, clinically accessible imaging techniques that probe molecular changes in GM.

OBJECTIVE - To study cortical GM pathology related to CI in MS using glutamate-sensitive chemical exchange saturation transfer (GluCEST) MRI at 7.0 Tesla (7T).

METHODS - A total of 20 patients with relapsing-remitting MS and 20 healthy controls underwent cognitive testing, anatomical imaging, and GluCEST imaging. Glutamate-sensitive image contrast was quantified for cortical GM, compared between cohorts, and correlated with clinical measures of CI.

RESULTS AND CONCLUSION - Glutamate-sensitive contrast was significantly increased in the prefrontal cortex of MS patients with accumulated disability ( < 0.05). In addition, glutamate-sensitive contrast in the prefrontal cortex was significantly correlated with symbol digit modality test ( = -0.814) and choice reaction time ( = 0.772) scores in patients ( < 0.05), suggesting that GluCEST MRI may have utility as a marker for GM pathology and CI.

MeSH Terms (12)

Adult Cerebral Cortex Cognitive Dysfunction Female Glutamic Acid Gray Matter Humans Magnetic Resonance Imaging Male Middle Aged Multiple Sclerosis White Matter

Connections (2)

This publication is referenced by other Labnodes entities: